Bard Access Systems Recalls PowerPICC SV Catheters
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bard Access Systems, Inc. is recalling 624 units of PowerPICC SV Catheters due to a supplier recall of lidocaine ampoules manufactured under deficient practices.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened Bard Access Systems, Inc. initiated a voluntary recall of specific PowerPICC SV Catheters because lidocaine ampoules included with the devices were manufactured under deficient manufacturing practices by the supplier.
Which Products Are Affected
- 1274108D PowerPICC SV Catheter 4 Fr Dual-Lumen, Lot Number: REKW2449, UDI-DI Code: 00801741087110
- 3173108D PowerPICC SV Catheter 3 Fr Single-Lumen, Lot Number: REKV2227, UDI-DI Code: 00801741027536 A total of 624 units are affected. Distribution includes the United States nationwide (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY) and Belgium.
What You Should Do Consumers should contact Bard Access Systems, Inc. regarding the recall. The recalling firm is located at 605 N 5600 W, Salt Lake City, UT 84116-3738.
Why This Matters The recall affects devices intended for short or long term peripheral access to the central venous system for intravenous therapy and blood sampling.
Source FDA recall number Z-2659-2026. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,184 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.